Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Testing effectiveness (Phase 2)Ended earlyNCT01240304
What this trial is testing

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Arkansas 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03806309
What this trial is testing

OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaLocally Advanced CancerMetastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 106
Testing effectiveness (Phase 2)UnknownNCT06168552
What this trial is testing

Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Zhejiang University 20
Early research (Phase 1)Study completedNCT01383538
What this trial is testing

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinomaPancreatic Neoplasms
Andrew Ko 15
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)WithdrawnNCT04130399
What this trial is testing

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
Indiana University
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableStudy completedNCT02241187
What this trial is testing

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 2
Not applicableStudy completedNCT01905384
What this trial is testing

Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction

Who this might be right for
Distal Bile Duct Obstruction
Vanderbilt University Medical Center 6
Not applicableEnrolling By InvitationNCT06276764
What this trial is testing

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Who this might be right for
IPMN, PancreaticPancreas CancerPancreatic Cyst
Adenocyte, LLC 500
Not applicableLooking for participantsNCT04575363
What this trial is testing

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
CHU de Reims 90
Testing effectiveness (Phase 2)Study completedNCT02562898
What this trial is testing

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Margaret Tempero 18
Testing effectiveness (Phase 2)Looking for participantsNCT04990609
What this trial is testing

EUS-RFA PANCARDINAL-1 Trial

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
The University of Texas Health Science Center, Houston 60
Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Testing effectiveness (Phase 2)Study completedNCT00131911
What this trial is testing

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Study completedNCT01964287
What this trial is testing

First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma.

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 78
Testing effectiveness (Phase 2)Study completedNCT00260364
What this trial is testing

Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 44
Testing effectiveness (Phase 2)Study completedNCT02143219
What this trial is testing

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Metastatic CancerToxicity
Institut Cancerologie de l'Ouest 72
Next Page